118 related articles for article (PubMed ID: 15869593)
1. The antigenic binding site(s) of antibodies to factor XII associated with the antiphospholipid syndrome.
Harris SL; Jones DW; Gallimore MJ; Nicholls PJ; Winter M
J Thromb Haemost; 2005 May; 3(5):969-75. PubMed ID: 15869593
[TBL] [Abstract][Full Text] [Related]
2. Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII.
Jones DW; Gallimore MJ; MacKie IJ; Harris SL; Winter M
Br J Haematol; 2000 Sep; 110(3):721-6. PubMed ID: 10997986
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to factor XII are distinct from antibodies to prothrombin in patients with the anti-phospholipid syndrome.
Jone DW; Nicholls PJ; Donohoe S; Gallimore MJ; Winter M
Thromb Haemost; 2002 Mar; 87(3):426-30. PubMed ID: 11916074
[TBL] [Abstract][Full Text] [Related]
4. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach.
Citarella F; te Velthuis H; Helmer-Citterich M; Hack CE
Thromb Haemost; 2000 Dec; 84(6):1057-65. PubMed ID: 11154114
[TBL] [Abstract][Full Text] [Related]
5. Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces.
Citarella F; Ravon DM; Pascucci B; Felici A; Fantoni A; Hack CE
Eur J Biochem; 1996 May; 238(1):240-9. PubMed ID: 8665943
[TBL] [Abstract][Full Text] [Related]
6. The antigenic binding sites of autoantibodies to factor XII in patients with recurrent pregnancy losses.
Inomo A; Sugi T; Fujita Y; Matsubayashi H; Izumi S; Mikami M
Thromb Haemost; 2008 Feb; 99(2):316-23. PubMed ID: 18278180
[TBL] [Abstract][Full Text] [Related]
7. Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus.
Bertolaccini ML; Mepani K; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2007 Apr; 66(4):533-6. PubMed ID: 17020907
[TBL] [Abstract][Full Text] [Related]
8. Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes.
Mahdi F; Madar ZS; Figueroa CD; Schmaier AH
Blood; 2002 May; 99(10):3585-96. PubMed ID: 11986212
[TBL] [Abstract][Full Text] [Related]
9. Factor XII and kininogen asymmetric assembly with gC1qR/C1QBP/P32 is governed by allostery.
Kaira BG; Slater A; McCrae KR; Dreveny I; Sumya U; Mutch NJ; Searle M; Emsley J
Blood; 2020 Oct; 136(14):1685-1697. PubMed ID: 32559765
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to factor XII associated with lupus anticoagulant.
Jones DW; Gallimore MJ; Harris SL; Winter M
Thromb Haemost; 1999 Mar; 81(3):387-90. PubMed ID: 10102466
[TBL] [Abstract][Full Text] [Related]
11. Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domains.
Shamanaev A; Ivanov I; Sun MF; Litvak M; Srivastava P; Mohammed BM; Shaban R; Maddur A; Verhamme IM; McCarty OJT; Law RHP; Gailani D
Blood Adv; 2022 May; 6(10):3142-3154. PubMed ID: 35086137
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.
Wuillemin WA; Furlan M; Stricker H; Lämmle B
Thromb Haemost; 1992 Feb; 67(2):219-25. PubMed ID: 1621242
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to factor XII: a possible predictive marker for recurrent foetal loss.
Jones DW; Gallimore MJ; Winter M
Immunobiology; 2003; 207(1):43-6. PubMed ID: 12638902
[TBL] [Abstract][Full Text] [Related]
14. Significance of IgG for the activity of factor XII measured in human plasma.
Briseid K; Hoem NO; Johannesen S; Vangen AM; Westgaard T
Scand J Clin Lab Invest; 1996 Dec; 56(8):725-34. PubMed ID: 9034354
[TBL] [Abstract][Full Text] [Related]
15. A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain.
Ivanov I; Matafonov A; Sun MF; Mohammed BM; Cheng Q; Dickeson SK; Kundu S; Verhamme IM; Gruber A; McCrae K; Gailani D
Blood; 2019 Mar; 133(10):1152-1163. PubMed ID: 30591525
[TBL] [Abstract][Full Text] [Related]
16. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.
Citarella F; Fedele G; Roem D; Fantoni A; Hack CE
Blood; 1998 Dec; 92(11):4198-206. PubMed ID: 9834224
[TBL] [Abstract][Full Text] [Related]
17. ELISA for determination of total coagulation factor XII concentration in human plasma.
Madsen DE; Sidelmann JJ; Overgaard K; Koch C; Gram JB
J Immunol Methods; 2013 Aug; 394(1-2):32-9. PubMed ID: 23639297
[TBL] [Abstract][Full Text] [Related]
18. Identification of the factor XII contact activation site enables sensitive coagulation diagnostics.
Heestermans M; Naudin C; Mailer RK; Konrath S; Klaetschke K; Jämsä A; Frye M; Deppermann C; Pula G; Kuta P; Friese MA; Gelderblom M; Sickmann A; Preston RJS; Nofer JR; Rose-John S; Butler LM; Salomon O; Stavrou EX; Renné T
Nat Commun; 2021 Sep; 12(1):5596. PubMed ID: 34552086
[TBL] [Abstract][Full Text] [Related]
19. Coagulation factor XII Locarno: the functional defect is caused by the amino acid substitution Arg 353-->Pro leading to loss of a kallikrein cleavage site.
Hovinga JK; Schaller J; Stricker H; Wuillemin WA; Furlan M; Lämmle B
Blood; 1994 Aug; 84(4):1173-81. PubMed ID: 8049433
[TBL] [Abstract][Full Text] [Related]
20. A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation.
Hofman ZLM; Clark CC; Sanrattana W; Nosairi A; Parr NMJ; Živkovic M; Krause K; Mahnke NA; Scheffel J; Hack CE; Maurer M; de Maat S; Maas C
J Biol Chem; 2020 Jan; 295(2):363-374. PubMed ID: 31771982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
